Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/1205184.pdf
Reference39 articles.
1. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P . 1997 Curr. Biol. 7: 261–269
2. Bardelli A, Basile ML, Audero E, Giordano S, Wennstrom S, Menard S, Comoglio PM, Ponzetto C . 1999 Oncogene 18: 1139–1146
3. Baselga J, Tripathy D, Mendelsohn J, Baughman S, Benz CC, Dantis L, Sklarin NT, Seidman AD, Hudis CA, Moore J, Rosen PP, Twaddell T, Henderson IC, Norton L . 1996 J Clin Oncol 14: 737–744
4. Casamayor A, Morrice NA, Alessi DR . 1999 Biochem J 342: 287–292
5. Czar MJ, Galigniana MD, Silverstein AM, Pratt WB . 1997 Biochemistry 36: 7776–7785
Cited by 235 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review;Medicine;2024-06-14
2. Promising Role of Phytochemicals in the Prevention and Treatment of Cancer;Anti-Cancer Agents in Medicinal Chemistry;2022-12
3. Novel Therapies and Strategies to Overcome Resistance to Anti-HER2-Targeted Drugs;Cancers;2022-09-19
4. Gene expression trend changes in breast cancer populations over two decades: insights from The Cancer Genome Atlas database;Hereditas;2022-03-22
5. Bayesian multistudy factor analysis for high-throughput biological data;The Annals of Applied Statistics;2021-12-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3